Please login to the form below

Not currently logged in
Email:
Password:

Havas appoints Ben Davies as European CEO

He will take over from Ed Stapor at the healthcare communications agency

Havas European CEO Ben DaviesHavas Worldwide Health has appointed Ben Davies as the new CEO of its European division.

The former CEO of Pan Advertising officially starts at Havas on September 3, when he takes over from Ed Stapor, who will continue at the agency until the end of the year and then take up a new role within the wider Havas network.

Davies has 26 years experience in healthcare marketing and advertising, latterly serving not just at Pan but also as co-founder and EU chair of Indigenus, the independent global network to which Pan belonged.

In his new role Davies will report to New York–based Havas Worldwide Health managing partners and CEOs Doug Burcin and Donna Murphy.

Commenting on the appointment, Burcin said: “We are very excited to welcome Ben to our team. His background in healthcare marketing and advertising is impressive and will be a tremendous contribution to our continued success in Europe.

“Ed's done a great job in this role and we have full confidence that under Ben's leadership, we will continue to grow and innovate in Europe.”

The agency has already boosted its UK operations this summer, acquiring Manchester-based digital agency Creative Lynx and appointing Davies' former colleague at Pan Claire Dobbs as managing director for its London office.

31st August 2012

Share


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMC

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....